Nitric Oxide Regulation of Myocardial Contractility and Calcium Cycling: Independent Impact of Neuronal and Endothelial Nitric Oxide Synthases
Overview
Authors
Affiliations
The mechanisms by which nitric oxide (NO) influences myocardial Ca2+ cycling remain controversial. Because NO synthases (NOS) have specific spatial localization in cardiac myocytes, we hypothesized that neuronal NOS (NOS1) found in cardiac sarcoplasmic reticulum (SR) preferentially regulates SR Ca2+ release and reuptake resulting in potentiation of the cardiac force-frequency response (FFR). Transesophageal pacing (660 to 840 bpm) in intact C57Bl/6 mice (WT) stimulated both contractility (dP/dtmax normalized to end-diastolic volume; dP/dt-EDV) by 51+/-5% (P<0.001) and lusitropy (tau; tau) by 20.3+/-2.0% (P<0.05). These responses were markedly attenuated in mice lacking NOS1 (NOS1-/-) (15+/-2% increase in dP/dt-EDV; P<0.001 versus WT; and no change in tau; P<0.01 versus WT). Isolated myocytes from NOS1-/- (approximately 2 months of age) also exhibited suppressed frequency-dependent sarcomere shortening and Ca2+ transients ([Ca2+]i) compared with WT. SR Ca2+ stores, a primary determinant of the FFR, increased at higher frequencies in WT (caffeine-induced [Ca2+]i at 4 Hz increased 107+/-23% above 1 Hz response) but not in NOS1-/- (13+/-26%; P<0.01 versus WT). In contrast, mice lacking NOS3 (NOS3-/-) had preserved FFR in vivo, as well as in isolated myocytes with parallel increases in sarcomere shortening, [Ca2+]i, and SR Ca2+ stores. NOS1-/- had increased SR Ca2+ ATPase and decreased phospholamban protein abundance, suggesting compensatory increases in SR reuptake mechanisms. Together these data demonstrate that NOS1 selectively regulates the cardiac FFR via influences over SR Ca2+ cycling. Thus, there is NOS isoform-specific regulation of different facets of rate-dependent excitation-contraction coupling; inactivation of NOS1 has the potential to contribute to the pathophysiology of states characterized by diminished frequency-dependent inotropic responses.
Panday N, Sigdel D, Adam I, Ramirez J, Verma A, Eranki A Antioxidants (Basel). 2024; 13(11).
PMID: 39594561 PMC: 11590986. DOI: 10.3390/antiox13111420.
Mosqueira M, Scheid L, Kiemel D, Richardt T, Rheinberger M, Ollech D Front Physiol. 2022; 13:946682.
PMID: 36045747 PMC: 9421439. DOI: 10.3389/fphys.2022.946682.
Effects of arginase inhibition on myocardial Ca and contractile responses.
Cho J, Han Y, Jensen C, Sieck G Physiol Rep. 2022; 10(14):e15396.
PMID: 35866269 PMC: 9305075. DOI: 10.14814/phy2.15396.
Kulandavelu S, Dulce R, Murray C, Bellio M, Fritsch J, Kanashiro-Takeuchi R J Am Heart Assoc. 2022; 11(5):e024008.
PMID: 35191317 PMC: 9075059. DOI: 10.1161/JAHA.121.024008.
Parshukova O, Varlamova N, Potolitsyna N, Lyudinina A, Bojko E Cells. 2022; 11(1).
PMID: 35011601 PMC: 8750590. DOI: 10.3390/cells11010039.